About
CovalX provides mass spectrometry-based analytical services for biotherapeutics, especially monoclonal antibodies, protein complexes, and other biologics. It serves pharmaceutical and biotechnology companies from locations in Zurich, Woburn, and Martillac, with support offices and laboratories in Switzerland, France, and the United States.
Services
HDX-MS Epitope Mapping
Maps antibody binding sites by measuring solvent protection changes in solution under native conditions.
XL-MS Epitope Mapping
Identifies epitope contacts by chemical cross-linking followed by nLC-MS/MS analysis.
De Novo Sequencing
Determines protein sequence information using mass spectrometry-based peptide analysis.
High-Resolution LC-MS
Confirms molecular weight and micro-heterogeneity of proteins and antibodies at the intact and subunit level.
High-Mass MALDI-MS
Measures intact mass of proteins and protein complexes up to 2 MDa from solution.
Sequence Verification (PMF)
Uses peptide mass fingerprinting to confirm primary sequence against the expected product.
Post-Translational Modifications (PTMs)
Identifies and localizes modifications such as oxidation, deamidation, and glycosylation.
Disulfide Mapping
Assigns disulfide bond connectivity under reducing and non-reducing conditions.
8 more services
- Free Sulfhydryl Analysis
- Glycan Analysis Services
- Aggregation Analysis
- Protein Interactions by MS
- IP-MS
- Drug Discovery Biophysical Testing
- Host Cell Protein Analysis
- Affinity : SPR & BLI
- Turnaround
- 3 weeks
- Two weeks or less
- What to send
- 200-300 µg of each protein
- 1 ng or less starting material for a given protein
- Sample types: 2D gel spots, SDS-PAGE bands, recombinant proteins, purified proteins
Capabilities
- Assays and studies
- Antibodies
- LC-MS/MS
- SPR
- Peptides
- BLI
- ADCs
11 more
- HDX-MS
- XL-MS
- LC-MS
- MALDI-MS
- PMF
- nLC-MS/MS
- DSC
- CD
- FTIR
- UV-Vis
- IP-MS
- Scale and capacity
- Up to 2 MDa
- Up to 200 kDa
- 200-300 µg of each protein
- 1 ng or less starting material
- 2 MDa for protein complexes
- Therapeutic areas
- Drug discovery
- Drug development
- Biotherapeutic development
Instruments and platforms
- Orbitrap
- High-Mass MALDI ToF
Modalities and species
- Modalities
- Antibody
- Bispecific
- ADC
- Peptide
- Viral vector
Company
- Type
- CRO
- Founded
- 2006
- Quality
- ICH Q6B (physicochemical characterization program for biological products submitted to FDA, EMA, and other major regulatory agenc)
Locations
- Address
- 12 Gill Street, Suite 4850 Woburn, MA 01801 United States
- Sites
- Zürich, Switzerland · Woburn, MA, United States · Martillac, France
- Serves
- Europe, United States, worldwide
Public records
- Wikidata
- Q5178883 source